Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Elevated expression of PTCD3 correlates with tumor progression and predicts poor prognosis in patients with prostate cancer.

Molecular medicine reports - 1 Oct 2018

Huang Yiqiao, Jiang Ganggang, Liang Xue, Lan Ziquan, Su Zhengming, Wu Hualing, Weng Jinsheng, Jiang Xianhan

Abstract excerpt

Pentatricopeptide repeat domain protein 3 (PTCD3) is a mitochondrial RNA‑binding protein that serves a role in mitochondrial translation. PTCD3 was originally reported as an oncogene that is involved in breast cancer and lymphoma. However, the expression and function of PTCD3 in prostate cancer (PCa) are unknown. Therefore, the aim of the present study was to investigate the expression of PTCD3 and its clinical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Disease-Free Survival
Share to Neoplasm Grading

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasm Invasiveness

Share to Neoplasm Metastasis

Share to Proportional Hazards Models

Share to Prostatic Neoplasms

Share to PTEN Phosphohydrolase

Share to RNA-Binding Proteins

Source

Open in PubMed Open full text

Identifiers

PMID: 30132530
DOI: 10.3892/mmr.2018.9402
PMCID: PMC6131642

Genes

BCR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Elevated expression of PTCD3 correlates with tumor progression and predicts poor prognosis in patients with prostate cancer.PMID 30132530Read ↗

Histone Demethylase KDM5C Drives Prostate Cancer Progression by Promoting EMTSemantic proximity Read ↗

Identification of metastasis-related genes for predicting prostate cancer diagnosis, metastasis and immunotherapy drug candidates using machine learning approachesSemantic proximity Read ↗

SMYD3 contributes to a more aggressive phenotype of prostate cancer and targets Cyclin D2 through H4K20me3.Semantic proximity Read ↗

TBC1D3, a hominoid oncoprotein, is encoded by a cluster of paralogues located on chromosome 17q12.Semantic proximity Read ↗

Overexpression of CDCA8 Predicts Poor Prognosis and Promotes Tumor Cell Growth in Prostate CancerSemantic proximity Read ↗

The SMYD3-MAP3K2 signaling axis promotes tumor aggressiveness and metastasis in prostate cancerSemantic proximity Read ↗

Phospholipase C Delta 3 inhibits apoptosis and promotes proliferation, migration, and invasion of thyroid cancer cells via Hippo pathwaySemantic proximity Read ↗

ZFC3H1 provides a reference to evaluate the prognosis and treat prostate adenocarcinoma: A study based on TCGA dataSemantic proximity Read ↗

METTL3 drives malignant progression in TP53-mutant prostate cancer.Semantic proximity Read ↗

Circular RNA circHIPK3 promotes cell proliferation and invasion of prostate cancer by sponging miR-193a-3p and regulating MCL1 expressionSemantic proximity Read ↗

Targeting CHD1L suppresses prostate cancer progression via the FOXO3-PUMA axisSemantic proximity Read ↗

Loss of ID3 drives papillary thyroid cancer metastasis by targeting E47-mediated epithelial to mesenchymal transitionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.